CRISPR May Prove Useful in De-Extinction Efforts

Researchers are using the powerful gene-editing tool to recreate the woolly mammoth.

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

GREYSTONE BOOKS, OCTOBER 2017There may come a day when woolly mammoth–like proxies with imposing curled tusks and that iconic, shaggy mane will traipse again through their ancestral stomping grounds in the Siberian tundra. The woolly mammoth went extinct after the last holdouts on Wrangle Island, off the northern coast of far eastern Siberia, died off between 3,600 and 4,000 years ago. For now, however, the promise of this futuristic vision lives in labs at Harvard Medical School—and the cells in petri dishes are a long way off from assembling into a complete animal. Researchers are nowhere close to recreating fully formed mammoths, and, thus far, scientific efforts to resurrect the extinct beasts have been rather incremental. But that hasn’t kept Harvard Medical School researcher George Church from predicting that he and his colleagues, who collaborate on a de-extinction project known as the Woolly Mammoth Revival, will create a hybrid woolly mammoth-Asian elephant embryo as early as 2019. And CRISPR-Cas9, a gene-editing technology that Church’s lab played a role in developing, may be the key to speeding the eventual return of the ancient animal.

I explore this and other tales of de-extinction in my book, Rise of the Necrofauna.

Bobby Dhadwar, a postdoctoral researcher in Church’s lab, has been laying some of the groundwork for creating the engineered embryos. Since the project’s early days, he has been involved in editing “background cell types” in order to test the effects certain woolly mammoth–specific genetic changes have on available cells that most resemble those of a mammoth: Asian elephant cells.

To start, Dhadwar and his colleagues identified traits that people normally attribute to the woolly mammoth, but that are missing in Asian elephants. These include an abundance of reddish-brown hair and a form of oxygen- binding hemoglobin that functions well at low temperatures. In their early experiments, the researchers went hunting ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Britt Wray

    This person does not yet have a bio.

Published In

September 2017

Healing with Hallucinogens

The therapeutic benefits of psychedelic drugs

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo